Beryl Capital Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-237,584
Closed -$9.41M 27
2024
Q4
$9.41M Sell
237,584
-751,320
-76% -$29.2M 2.13% 9
2024
Q3
$38.3M Sell
988,904
-553,128
-36% -$22.4M 8.28% 3
2024
Q2
$64.8M Buy
+1,542,032
New +$52.6M 19.49% 2

Other funds holding SRDX

Beryl Capital Management's SRDX Position: Q1 2025 in Review

Beryl Capital Management sold out of Surmodics (SRDX) in Q1 2025, closing a stake of 237,584 shares — an estimated $9.41M sold.

Beryl Capital Management first reported a position in SRDX in Q2 2024 and held it in 3 quarters. The position peaked at $64.8M in Q2 2024. 135 funds tracked by Wall St. Rank hold SRDX as of Q1 2025.

  • Beryl Capital Management reported no remaining Surmodics position as of Q1 2025 after selling out during the quarter.
  • Beryl Capital Management sold 237,584 Surmodics shares in Q1 2025, an estimated $9.41M.
  • Beryl Capital Management first reported a position in Surmodics in Q2 2024 and held it in 3 quarters.
  • Beryl Capital Management's Surmodics position peaked at $64.8M in Q2 2024.
  • 135 funds tracked by Wall St. Rank held Surmodics as of Q1 2025.

Based on Beryl Capital Management's 13F filing for Q1 2025, filed 15 May 2025.